The relationship between visual field loss in glaucoma and health-related quality-of-life

Eye

Volumn 24, Issue 12, 2010, Pages 1759-1769

  Van Gestel, A ^a   Webers, C A B ^a   Beckers, H J M ^a   Van Dongen, M C J M ^b   Severens, J L ^b,c   Hendrikse, F ^a   Schouten, J S A G ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

glaucoma; health related quality of life; treatment; utility; visual field loss

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; GLAUCOMA SURGERY; HUMAN; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; NETHERLANDS; OBSERVATIONAL STUDY; OPEN ANGLE GLAUCOMA; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; TRABECULOPLASTY; VISUAL ACUITY; VISUAL FIELD DEFECT;

EID: 78650206632     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2010.133     Document Type: Article

References (22)

1. Maier P, Funk J, Schwarzer G, Antes G, Falck-Ytter Y. Treatment of ocular hypertension and open angle glaucoma: Meta-analysis of randomised controlled trials. BMJ 2005; 331: 134.
2. Peeters A, Webers C, Prins M, Zeegers M, Hendrikse F, Schouten J. Quantifying the effect of intra-ocular pressure reduction on the occurrence of glaucoma. Acta Ophthalmol 2010; 88: 5-11.
3. Gutierrez P, Wilson M, Johnson C, Gordon M, Cioffi G, Ritch R et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol 1997; 115: 777-784. (Pubitemid 27276261)
4. Parrish R, Gedde S, Scott I, Feuer W, Schiffman J, Mangione C et al. Visual function and quality of life among patient with glaucoma. Arch Ophthalmol 1997; 115: 1447-1455. (Pubitemid 28055876)
5. McKean Cowdin R, Wang Y, Wu J, Azen SP, Varma R. Impact of visual field loss on health-related quality of life in glaucoma: The Los Angeles Latino Eye Study. Ophthalmology 2008; 115: 941-948.
6. Beckers HJ, Schouten JS, Webers CA, van der Valk R, Hendrikse F. Side effects of commonly used glaucoma medications: Comparison of tolerability, chance of discontinuation, and patient satisfaction. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1485-1490.
7. Nelson P, Aspinall P, Papasouliotis O, Worton B, O'Brien C. Quality of life in glaucoma and its relationship with visual function. J Glaucoma 2003; 12: 139-150.
8. Nelson P, Aspinall P, O'Brien C. Patients' perception of visual impairment in glaucoma: A pilot study. Br J Ophthalmol 1999; 83: 546-552.
9. Van der Sterre G, Van de Graaf E, Verezen C, Meulendijks C, Schouten J, Saxena R et al. National Eye Institute Visual Functioning Questionnaire-25: Dutch consensus translation (VFQ-25/NL). Erasmus Medical Center Rotterdam, department of Ophthalmology: Rotterdam, 2001.
10. Mangione C, Lee P, Pitts J, Gutierrez P, Berry S, Hays R et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol 1998; 116: 1496-1504.
11. Mangione C. NEI VFQ-25 scoring algorithm. 2000. Available at: http://www.nei.nih.gov/resources/visionfunction/ manual-cm2000.pdf. Accessed 23 June 2008.
12. Rabin R, de Charro F. EQ-5D: A measure of health status from the EuroQol Group. Ann Med 2001; 33: 337-343.
13. Lamers L, Stalmeier P, McDonnell J, Krabbe P, van Busschbach J. Measuring the quality of life in economic evaluations: The Dutch EQ-5D tariff. Ned Tijdschr Geneeskd 2005; 149: 1574-1578.
14. Torrance GW, Furlong W, Feeny D, Boyle M. Multi-attribute preference functions. Health Utilities Index. Pharmacoeconomics 1995; 7: 503-520.
15. Furlong W, Feeney D, Torrance G, Goldsmith C, DePauw S, Boyle M et al. Multiplicative multi-attribute utility function for the Health Utilities Index Mark 3 (HUI3) System: A Technical Report. Working Paper No 98-11 McMaster University Centre for Health Economics and Policy Analysis.
16. Donders A, Van der Heijden G, Stijnen T, Moons K. Review: A gentle introduction to imputation of missing values. J Clin Epidemiol 2006; 59: 1087-1091. (Pubitemid 44374314)
17. Ferris III FL, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 1982; 94: 91-96.
18. Nelson-Quigg J, Cello K, Johnson C. Predicting binocular visual field sensitivity from monocular visual field results. Invest Ophthalmol Vis Sci 2000; 41: 2212-2221.
19. Kobelt G, Jonsson B, Bergstrom A, Chen E, Linden C, Alm A. Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden. Acta Ophthalmol Scand 2006; 84: 363-371.
20. Burr J, Kilonzo M, Vale L, Ryan M. Developing a preferencebased glaucoma utility index using a discrete choice experiment. Optom Vis Sci 2007; 84: 797-808.
21. Aspinall P, Johnson Z, Azuara-Blanco A, Montarzino A, Brice R, Vickers A. Evaluation of quality of life and priorities of patients with glaucoma. Invest Ophthalmol Vis Sci 2008; 49: 1907-1915.
22. Janz N, Wren P, Lichter P, Musch D, Gillespie B, Guire K et al. The Collaborative Initial Glaucoma Treatment Study; Interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology 2001; 108: 1954-1965. (Pubitemid 33032761)